Anti-Golgi Antibody as a Potential Indicator for Rheumatoid Arthritis

被引:2
|
作者
Zhai, Jianzhao [1 ]
Liao, Jing [1 ]
Wang, Minjin [1 ]
Huang, Zhuochun [1 ]
Hu, Jing [1 ]
Xu, Huan [1 ]
Xie, Qibing [2 ]
Ma, Bin [3 ]
Baan, Carla C. [4 ]
Wu, Yongkang [1 ,5 ,6 ]
机构
[1] Sichuan Univ, West China Sch Med, West China Hosp, Dept Lab Med, Chengdu, Peoples R China
[2] Sichuan Univ, West China Hosp, Dept Rheumatol, Chengdu, Peoples R China
[3] Murdoch Univ, Sch Vet & Life Sci, Murdoch, WA, Australia
[4] Erasmus MC, Sect Nephrol Transplantat, Dept Internal Med, Rotterdam, Netherlands
[5] Sichuan Univ, Dept Outpatient, West China Hosp, Chengdu, Peoples R China
[6] Sichuan Univ, Natl Clin Res Ctr Geriatr, Chengdu, Peoples R China
关键词
anti-Golgi antibody; antinuclear antibodies; rheumatoid arthritis; autoimmune diseases; antibody titer; disease progression; AUTOANTIBODIES; COMPLEX; AUTOANTIGEN; PATIENT;
D O I
10.1093/labmed/lmab046
中图分类号
R446 [实验室诊断]; R-33 [实验医学、医学实验];
学科分类号
1001 ;
摘要
Objective To reveal the relationship between anti-Golgi antibody (AGA) and clinical diseases through retrospective analysis. Methods The clinical data of 584 cases testing positive for AGA in the past 11 years were collected and retrospectively analyzed. Results AGA pattern accounted for .2% of positive ANA results. In total, 35.0% of diagnosed patients had autoimmune diseases (AID), mainly rheumatoid arthritis (RA). High-titer AGA (>= 1:1000) was common in AID. In nondiagnosed patients with clinical symptoms, joint pain/muscle pain was the most common. Conclusions Positive AGA with high titer was closely related to RA. Joint pain/muscle pain was the most common symptom in patients who tested AGA positive. Therefore, AGA may be a key indicator of RA in the Chinese population.
引用
收藏
页码:156 / 160
页数:5
相关论文
共 50 条
  • [41] THE VALUE OF ANTI-CITRULLINATED PEPTIDE ANTIBODY IN THE DIAGNOSIS OF RHEUMATOID ARTHRITIS
    Doherty, Teresa
    Martin, Keith
    Ruth, Chen
    Panthakalam, Sathianathan
    RHEUMATOLOGY, 2010, 49 : I132 - I133
  • [42] Belimumab - an anti-BLyS human monoclonal antibody for rheumatoid arthritis
    Jin, Xingzhong
    Ding, Changhai
    EXPERT OPINION ON BIOLOGICAL THERAPY, 2013, 13 (02) : 315 - 322
  • [43] MEASUREMENT OF IGG ANTI-IGG ANTIBODY IN RHEUMATOID-ARTHRITIS
    ABRUZZO, JL
    HEIMER, R
    JOURNAL OF IMMUNOLOGICAL METHODS, 1974, 4 (02) : 149 - 160
  • [44] The role of Rheumatoid Factor and Anti-Cyclic Citrullinated Peptide Antibody in Diagnosis of Rheumatoid Arthritis
    Mobini, M.
    Kashi, Z.
    Mahdavi, M. R.
    IRANIAN RED CRESCENT MEDICAL JOURNAL, 2010, 12 (02) : 100 - 103
  • [45] Anti-citrullinated procollagen C-endopeptidase enhancer antibody (anti-PCOLCE): a potential biomarker for seronegative rheumatoid arthritis
    Lin, Hongying
    Xie, Yang
    Wei, Xihua
    Wei, Chaonan
    Li, Zhanguo
    Hu, Fanlei
    RHEUMATOLOGY, 2025,
  • [46] A Novel Humanized Anti-Interleukin-6 Antibody HZ0408b With Anti-Rheumatoid Arthritis Therapeutic Potential
    Liu, Xiaolei
    Li, Li
    Wang, Qian
    Jiang, Fengchao
    Zhang, Pei
    Guo, Fei
    Liu, Hongjun
    Huang, Jian
    FRONTIERS IN IMMUNOLOGY, 2022, 12
  • [47] ANTI-CITRULLINATED PROTEIN ANTIBODY AND RHEUMATOID FACTOR PROFILES PREDICT THE DEVELOPMENT OF RHEUMATOID ARTHRITIS
    Lingampalli, Nithya
    Sokolove, Jeremy
    Robison, William H.
    JOURNAL OF CLINICAL IMMUNOLOGY, 2016, 36 (03) : 290 - 291
  • [48] Impact of Anti-Citrullinated Protein Antibody and/or Rheumatoid Factor on Rheumatoid Arthritis Manifestations and Outcomes
    Koh, Ee Tzun
    Chan, Angela Marie
    See, Wei Qiang
    Xiang, Wenwei
    Leong, Khai Pang
    ARTHRITIS & RHEUMATOLOGY, 2016, 68
  • [49] Rethink about the role of rheumatoid factor and anti-citrullinated protein antibody in rheumatoid arthritis
    Sung, Wang Yu
    Tsai, Wen Chan
    RHEUMATOLOGY AND IMMUNOLOGY RESEARCH, 2021, 2 (01): : 19 - 25
  • [50] Clinical Pharmacology and Therapeutic Potential of Monoclonal Antibody Treatment in Rheumatoid Arthritis
    Ernest H. S. Choy
    Drugs & Aging, 1998, 12 : 139 - 148